Cerba Research
Cerba Research is a major clinical trial laboratory services provider connected to Cerba HealthCare’s broader diagnostics platform. The organization supports clinical development programs through central laboratory services, specialty testing, biomarker development, genomics, flow cytometry, pathology, and clinical trial sample management.
- Highest 2026 tier: Tier II
- Clinical Trial & Research Laboratories
- 1 ranking category
Overview
Cerba Research is a major clinical trial laboratory services provider connected to Cerba HealthCare’s broader diagnostics platform. The organization supports clinical development programs through central laboratory services, specialty testing, biomarker development, genomics, flow cytometry, pathology, and clinical trial sample management.
Cerba Research is especially relevant for complex and specialty clinical trials where sponsors require scientific consultation and assay flexibility. Its laboratory services support oncology, infectious disease, immunology, rare disease, and precision medicine studies.
Cerba Research is included in 1 2026 ranking category. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.
Firm facts
| Public identity | Cerba Research |
| Founded | 1998 |
| Institution type | Clinical Trial & Research Laboratories institution |
| Headquarters | Ghent / Paris, Belgium and France |
| Primary focus | Clinical Trial & Research Laboratories |
| Highest 2026 ranking tier | Tier II |
Principal activities
Cerba Research is especially relevant for complex and specialty clinical trials where sponsors require scientific consultation and assay flexibility. Its laboratory services support oncology, infectious disease, immunology, rare disease, and precision medicine studies.
Core capability
Clinical Trial & Research Laboratories
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Clinical Trial & Research Laboratories
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
The company’s strength lies in combining global clinical trial laboratory services with specialist scientific capabilities. Its connection to a broader healthcare diagnostics organization also supports access to pathology expertise, clinical laboratory infrastructure, and international laboratory operations.
Cerba Research is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. Cerba Research should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as Cerba Research. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | Cerba Research |
| Headquarters | Ghent / Paris, Belgium and France |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Clinical Trial & Research Laboratories 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
